Valuation: ATTANA AB

Market Cap 7.74M 780K 686K 646K 590K 1.1M 74.85M 1.11M 3M 38.21M 2.93M 2.87M 125M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 765K 673K 634K 579K 1.08M 73.45M 1.09M 2.95M 37.49M 2.87M 2.81M 122M EV / Sales 2024
0.91x
EV / Sales 2025 8.11x
Free-Float
6.54%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/04/2025
Chief Executive Officer 56 01/09/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 06/08/2012
Chairman 63 01/10/2015
Director/Board Member 62 01/01/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 781K
+0.53%-14.03% - - 1.18B
-1.26%-0.42%-33.76%-37.86% 695M
+0.18%+1.08%+58.49% - 357M
+0.59%+8.22%-40.54%-23.60% 127M
-1.60%-6.12%-16.74%+15.72% 71.91M
Average -0.26%-0.39%-8.14%-15.25% 486.81M
Weighted average by Cap. -0.09%-2.43%-7.14%-31.53%

Financials

2024 2025
Net sales 4.1M 414K 363K 342K 313K 585K 39.68M 590K 1.59M 20.25M 1.55M 1.52M 66.17M 2.47M 249K 219K 206K 189K 353K 23.91M 356K 959K 12.2M 936K 915K 39.87M
Net income -12.78M -1.29M -1.13M -1.07M -974K -1.82M -124M -1.84M -4.96M -63.06M -4.83M -4.73M -206M -10.5M -1.06M -930K -876K -801K -1.5M -102M -1.51M -4.08M -51.83M -3.97M -3.89M -169M
Net Debt 1.17M 118K 104K 97.69K 89.29K 167K 11.32M 168K 454K 5.78M 443K 433K 18.88M -145K -14.65K -12.88K -12.13K -11.09K -20.74K -1.41M -20.92K -56.43K -718K -55.03K -53.83K -2.35M
Logo ATTANA AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
-